Scalp acupuncture for parkinson's disease: A systematic review of randomized controlled trials

Chinese Journal of Integrative Medicine

Volumn 19, Issue 4, 2013, Pages 297-306

  Lee, Hun Soo ^a   Park, Hye Lim ^a   Lee, Seung Jin ^a   Shin, Byung Cheul ^a   Choi, Jun Yong ^a   Lee, Myeong Soo ^b  

^a Pusan National University   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Metaanalysis; Parkinson's disease; Randomized controlled trials; Scalp acupuncture; Systematic review

Indexed keywords

AMANTADINE; BENSERAZIDE PLUS LEVODOPA; LEVODOPA; TRIHEXYPHENIDYL;

ACUPUNCTURE; CLINICAL PROTOCOL; DATA ANALYSIS; HUMAN; META ANALYSIS; METHODOLOGY; MOTOR DYSFUNCTION; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCALP ACUPUNCTURE; STATISTICAL BIAS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; PATHOLOGY; SCALP;

ACUPUNCTURE POINTS; ACUPUNCTURE THERAPY; HUMANS; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCALP; TREATMENT OUTCOME;

EID: 84885622751     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-013-1431-9     Document Type: Review

References (37)

1. Yu CD, Wu BH, Zhang J, Song HM, Wang GS, Yu Z. Effect of skull acupuncture and scalp acupuncture on serum vascular endothelial growth factor in the patient of acute cerebral infarction. Chin Acupunct Moxibust (Chin) 2006;26:466-468.
2. Jennum P, Zoetmulder M, Korbo L, Kjellberg J. The healthrelated, social, and economic consequences of parkinsonism: a controlled national study. J Neurol 2011;258:1497-1506.
3. National Guideline Clearinghouse. Parkinson's disease. http:/www.guideline.gov/content.aspx?id=32493&search=parkinson [accessed 11.05.12].
4. Sweet RD, McDowell FH. Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients. Ann Intern Med 1975;83:456-463.
5. Verhagen ML. Recognition and treatment of response fluctuations in Parkinson's disease: review article. Amino Acids 2002;23:141-145.
6. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5:525-535.
7. Wang FC, ed. Scalp acupuncture therapy. Beijing: People's Medical Publishing House; 2007:4-7.
8. Schockert T, Schnitker R, Boroojerdi B, Smith IQ, Yamamoto T, Vietzke K, et al. Cortical activation by Yamamoto new scalp acupuncture in the treatment of patients with a stroke: a sham-controlled study using functional MRI. Acupunct Med 2010;28:212-214.
9. Zheng GQ, Wang Y, Wang XT. Literature foundation of scalp-acupuncture treatment of cerebral hemorrhage and its recent progress in clinical research. Acupunct Res 2006;31:181-184.
10. Lee MS, Shin BC, Kong JC, Ernst E. Effectiveness of acupuncture for Parkinson's disease: a systematic review. Mov Disord 2008;23:1505-1515.
11. Lam YC, Kum WF, Durairajan SS, Lu JH, Man SC, Xu M, et al. Efficacy and safety of acupuncture for idiopathic Parkinson's disease: a systematic review. J Altern Compl Med 2008;14:663-671.
12. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
13. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010;63(8):e1-e37.
14. MacPherson H, Altman DG, Hammerschlag R, Li Y, Wu T, White A, et al. Revised Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med 2010;28(2):83-93.
15. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003;18:738-750.
16. Nouzeilles MI, Merello M. Correlation between results of motor section of UPDRS and Webster Scale. Mov Disord 1997;12:613.
17. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, et al. Movement Disorder Society Task Force Report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004;19:1020-1028.
18. McRae C, Diem G, Vo A, O'Brien C, See berger L. standardization of administration. Mov Disord 2000;15:335-336.
19. Baas H, Stecker K, Fischer PA. Value and appropriate use of rating scales and apparative measurements in quantifitarion of disability in Parkinson's disease. J Neural Trans 1993;5:45-61.
20. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
21. Jiang XM, Huang Y, Li DJ, Tang AW, Wang SX, Zhuo Y, et al. Effect of electro-scalp acupuncture on cerebral dopamine transporter in the striatum area of the patient of Parkinson's disease by means of single photon emission computer tomography. Chin Acupunct Moxibust (Chin) 2006;26:427-430.
22. Huang Y, Jiang X, Zhuo Y, Tang A, Wik G. Complementary acupuncture treatment increases cerebral metabolism in patients with Parkinson's disease. Int J Neurosci 2009;119:1190-1197.
23. Huang Y, Zhuo Y, Jiang XM, Tang AW, LI DJ, Shao M, et al. Effect of scalp acupuncture on regional cerebral blood flow in Parkinson's disease patients. Chin J Integr Tradit West Med (Chin) 2009;24:305-308.
24. Jiang XM, Huang Y, Zhuo Y, Gao YP. Therapeutic effect of scalp electroacupuncture on Parkinson disease. J South Med Univ (Chin) 2006;26:114-116.
25. Yang Y, Chen HT. Clinical observation on the treatment of parkinson's disease by scalp. JCAM 2004;20(6):36.
26. Zhang WG, Wang GB, Qin Y. Scalp acupuncture for treatment of Parkinson disease: 32 cases. Guangming J Chin Med (Chin) 2002;17(3):55-56.
27. Wang YZ. Enlightenment and thinking on Deqi (arrival of needling sensation) by abdominal acupuncture. Chin Acupunct Moxibust (Chin) 2011;31:183-185.
28. Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998;19:159-166.
29. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323:42-46.
30. Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978;299:690-694.
31. Park J, White A, Stevinson C, Ernst E, James M. Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med 2002;20:168-174.
32. Golub RM, Fontanarosa PB. Comparative effectiveness research: relative successes. JAMA 2012;307:1643-1645.
33. Witt CM, Manheimer E, Hammerschlag R, Ludtke R, Lao L, Tunis SR, et al. How well do randomized trials inform decision making: systematic review using comparative effectiveness research measures on acupuncture for back pain. PLoS One 2012;7:e32399.
34. Zhang HX, Liu LG, Zhou L, Huang H, Li X, Yang M. Effect of scalp acupuncture on inflammatory response in rats with acute cerebral ischemia-reperfusion injury. J Chin Integr Med (Chin) 2007;5:686-691.
35. Inoue I, Chen L, Zhou L, Zeng X, Wang H. Reproduction of scalp acupuncture therapy on strokes in the model rats, spontaneous hypertensive rats-stroke prone (SHR-SP). Neurosci Lett 2002;333:191-194.
36. Vincent C, Lewith G. Placebo controls for acupuncture studies. J R Soc Med 1995;88:199-202.
37. White A, Cummings M, Barlas P, Cardini F, Filshie J, Foster NE, et al. Defining an adequate dose of acupuncture using a neurophysiological approach-a narrative review of the literature. Acupunct Med 2008;26:111-120.